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ABSTRACT: Herein reports the ruthenium-catalyzed ortho-C-H alkenylation of a wide range of N-aryloxazolidinone scaffolds. 
Alkenylation was achieved with complete mono-selectivity with a scope of 27 examples in 2-MeTHF. Yields ranged from 23-94% 
creating highly decorated oxazolidinone scaffolds. A kinetically relevant C-H cleavage was also observed with a KIE ~ 2. DFT 
calculations elucidated information on mechanism, detailing the β-hydride elimination as the most energetically challenging step of 
+13.5 kcalmol-1. In-depth computational kinetic studies also predicted a KIE of 2.17 for C-H cleavage and an intrinsic KIE for the 
reaction of 2.22, in line with the experimentally observed value.   
  The oxazolidinone heterocycle is prevalent in pharmaceuti-
cally active compounds with widespread bioactivity for exam-
ple Linezolid1, Tedizolid2 (antibacterial, Figure 1), Rivaroxa-
ban3 (anti-coagulant) and Toloxatone4 (antidepressant). For 
these reasons the synthesis of these heterocycles and their mod-
ification has received great attention in recent years.5 These bi-
ologically active structures contain the oxazolidinone heterocy-
cle neighboring an aromatic ring. This makes these structures 
prime for investigation as directing groups in C-H functionali-
zation catalysis. 
  
Figure 1: Pharmacologically active compounds containing the ox-
azolidinone heterocycle.   
  Transition metal catalyzed C-H functionalization has become 
a vital synthetic tool to facilitate the formation of useful C-C 
and C-X bonds.6 This methodology transforms latent C-H 
bonds into potentially reactive functional groups. Harnessing 
this concept to allow derivatization of biologically active com-
pounds such as the oxazolidinones is a very attractive strategy 
to enable the synthesis of drug analogues through expedient 
late-stage modification.7 
  Ruthenium catalyzed C-H bond functionalization has seen 
widespread application into the modern synthetic world due to 
pioneering developments from Oi and Inoue, Ackermann, and 
Bruneau and Dixneuf8. Methodology has evolved rapidly to uti-
lize weakly coordinating carbonyl directing groups to install di-
verse functionality.9 This functionality is often ubiquitous in 
chemical structures; however, if necessary, an auxiliary ap-
proach can be used which involves separate installation and re-
moval steps.9k The presented study is focused on the utility of 
directing groups with intrinsic biological activity and how they 
facilitate C-H insertion via chelation assistance (Scheme 1). De-
spite early work reporting palladium catalyzed ortho-arylation 
of the 3-aryl-2-oxazolidinone structure, the motif has not been 
widely used as a directing group and there have been no such 
examples employing ruthenium catalysis.10  
Scheme 1: Ruthenium Catalyzed Alkenylation of Arenes 
 
 Optimization 
  The envisioned reaction methodology was probed using 3-
phenyl-2-oxazolidinone (1a) and ethyl acrylate (2a). The elec-
tron deficient nature of acrylates has shown them to be excellent 
coupling partners in ruthenium, palladium and rhodium cata-
lyzed C-H functionalization reactions.9a,11 A summary of the 
optimization is displayed in Table 1. 
Table 1: Optimization of Oxazolidinone Directed C-H 
Alkenylationa 
 
aGeneral Reaction Conditions: 1a – 1 mmol, 2a – 3 mmol, 
[RuCl2(p-cymene)] (2.5 mol%), AgSbF6 (20 mol%), Solvent (4 
mL). b 1H NMR conversion. cIsolated Yields after purification. dA-
gOAc (2 eq). eWithout [RuCl2(p-cymene)]2. fWithout AgSbF6. 
gReaction performed at 100 °C hAgSbF6 (10 mol%). iSolvent (1 
mL) 
  Starting conditions were obtained from literature precedent for 
the use of ruthenium, silver and copper in cooperative catalysis 
for similar transformations (full optimization information is 
available in the supporting information).9f,h,i,k  Alkenylation was 
observed DCE in low conversions (entry1). Much more sub-
stantial formation of product was observed with higher boiling 
polar aprotic etheric solvents (1,4-dioxane, DME and 2-
MeTHF, entries 2-4). A 2-MeTHF/AcOH mixture was interest-
ingly shown to completely nullify reactivity (entry 5) as AcOH 
is a proposed by-product in the reaction. 2-MeTHF was carried 
forward as solvent as choice as is a more sustainably sourced 
alternative to DME.12 
Multiple silver(I) oxidants were investigated with none show-
ing superior activity to Cu(OAc)2 (entries 6-9). However, the 
mono-hydrate complex was not only tolerated but shown to ac-
celerate catalysis (entry 10). Only oxidants containing carbox-
ylate counter ions promoted the reaction. This is in line with 
literature precedent for a concerted metalation-deprotonation 
(CMD) or ambiphilic metal-ligand activation (AMLA) mecha-
nism of C-H metalation.6a,b  
It must be noted that reaction efficacy was not maintained in the 
absence of either ruthenium catalyst or silver co-catalyst (en-
tries 11-12), however it was possible to decrease silver co-cata-
lyst loading without detriment to the reaction (entry 14). Fi-
nally, the reaction was shown to proceed with equal if not supe-
rior reactivity at higher concentration and proceeding with ex-
cellent catalytic efficiency under air (entry 15). Here oxygen in 
the atmosphere aids oxidant recycling.8a Also noteworthy was 
that throughout this optimization there was no observation of o-
,o-di-alkenylated product either by NMR or TLC. This high 
level of selectivity is an attractive feature.6b, 8a 
Reaction Scope 
  With optimized conditions in hand, 3-phenyl-2-oxazolidinone 
(1a) was reacted with a variety of electron deficient and electron 
rich alkenes to explore the scope of this catalytic transformation 
(Scheme 2). 
Scheme 2: Acrylate Scope of Oxazolidinone Directed C-H 
Alkenylation 
 
Excellent catalytic activity was maintained using methyl, n-bu-
tyl and benzyl acrylates showing yields up to 94%. Unfortu-
nately the reaction did not proceed with other electron deficient 
alkenes and electron rich alkenes due to lack of reactivity or 
high volatility of substrates in open atmosphere (see supporting 
information). Despite this, similar structures can be accessed 
from 3a-d through functional group interconversions. The use 
of methyl acrylate enabled more facile purification via standard 
chromatographic methods (cf. benzyl) as well as superior iso-
lated yields (cf. ethyl). Due to this, methyl acrylate was carried 
forward as the acrylate of choice for expansion of the scope with 
aryl oxazolidinones (Scheme 3). 
  The reaction was shown to tolerate a wide variety of function-
ality on the aryl ring including fluoro-, chloro-, bromo-, alkoxy-
, aryl, and alkyl. Highest yields were achieved using electron 
rich substituents (3ab, 3ac, 3ai, 3aj). Yields were reduced when 
using highly electron deficient arenes with substituents such as 
CF3 or m-p-Cl (3ag & 3an). These patterns in reaction effi-
ciency are consistent with similar reported methodology.8k Un-
symmetrical examples such as 3-methyl and 3-chloro (3ai-3an) 
gave major isomers based on the least sterically hindered site 
with excellent selectivity. An ortho-substituted example (3ao) 
was also tolerated however in reduced yield. Heteroaromatics 
could also be functionalized with excellent efficiency demon-
strated with thiophene derivative (3ap).  
 
Entry Solvent Oxidant 3ab 
1 DCE Cu(OAc)2 15 
2 1,4-dioxane Cu(OAc)2 56 
3 DME Cu(OAc)2 72 (68)
c 
4 2-MeTHF Cu(OAc)2 70 (67)
c 
5 2-MeTHF/AcOH 
3:1 
Cu(OAc)2 - 
6 2-MeTHF Ag2CO3 13 
7 2-MeTHF AgOAc 48 
8 2-MeTHF AgOAcd 64 
9 2-MeTHF AgO2CCF3 Trace 
10 2-MeTHF Cu(OAc)2·H2O 77 
11e 2-MeTHF Cu(OAc)2·H2O - 
12f 2-MeTHF Cu(OAc)2·H2O - 
13g 2-MeTHF Cu(OAc)2·H2O 68 
14h 2-MeTHF Cu(OAc)2·H2O 78 
15h,i 2-MeTHF Cu(OAc)2·H2O 80 (76)
c 
 Scheme 3: Arene Scope of Oxazolidinone Directed C-H 
Alkenylation 
     
  Structures bearing a fluoro substituent meta- to the oxazoli-
dinone directing group (3aq & 3ar) gave a mixture of regioiso-
mers (Scheme 4), separable via column chromatography.  
Scheme 4: Oxazolidinone Directed C-H Alkenylation of 
Structures Bearing meta-Fluoro Substituent 
  
Regioisomers of structure 3aq gave an impressive combined 
yield of 91% and were further characterized by single crystal 
X-ray crystallography to confirm regiochemistry.13 These vali-
dated that the electronics of the system dictate the selectivity in 
these structures. This insight in selectivity is mirrored in a pre-
vious report in a benzamide assisted C-H cyanation reaction.14 
3ar gave a similar distribution of C-H alkenylated products 
with comparable isomer ratios albeit in lower yield. 
  Functionalization of the heterocycle itself was then varied us-
ing structures synthesized from natural amino acids valine and 
leucine (Scheme 5a). These substrates performed with good ef-
ficiency for such highly functionalized motifs. Yields were re-
duced with larger alkyl derivatives due to potential disruption 
of directing group C-H alignment, highlighted with 3bd.  
Methanol derivative (1ca) bearing functionality in the 5-posi-
tion was reacted under the catalytic conditions (Scheme 5b). 
The reaction conditions led to some undesired removal of the 
silyl protecting group. Due to this, the crude mixture was sub-
mitted to an in situ deprotection to afford the primary alcohol 
structure. One pot methodology was pleasingly shown to man-
ifest comparable efficiency to sequential isolation and separate 
deprotection. This allows for more expedient synthesis and re-
duced waste from work-up and purification. This methodology 
now allowed the synthesis of highly decorated oxazolidinone 
structures. 
Scheme 5: Heterocycle Scope of Oxazolidinone Directed C-
H Alkenylation 
 
  This methodology was shown to be scalable affording over 2 
grams’ worth of alkenylated product (Scheme 6). On a gram 
scale the lowering of ruthenium and silver loadings afforded a 
77% yield along with a 22% yield of recovered starting mate-
rial. 
  Interestingly there was still no observed presence of a di-
alkenylated structure, which was also not observed throughout 
the scope of the reaction. Complete mono-substitution selectiv-
ity in C-H functionalization methodology is highly sought after. 
To investigate this further, mono-alkenylated product 3b was 
re-exposed to the optimized reaction conditions in an attempt to 
 force formation of the di-alkenylated product 3bdi (Scheme 7). 
Despite this, no sign of this product was observed via TLC or 
crude NMR where only starting material was present. This 
highlighted the absolute selectivity of the oxazolidinone direct-
ing group towards mono-functionalization.  
Scheme 6: Gram Scale Ruthenium Catalyzed C-H Alkenyl-
ation 
 
Scheme 7: Attempted Di-Alkenylation of Mono-Substituted 
Structure 3b   
 
  The introduction of ester and alkene functionality to the com-
pound allows further derivation to form more complex and dec-
orated structures. Heterogeneous hydrogenation allowed access 
to the ortho-alkylated motif in quantitative yield (4a, Scheme 
8). Selective mild saponification allowed hydrolysis of the ester 
(4b) without interaction with the oxazolidinone heterocycle. 
Amidation conditions also afforded the amide in good yields 
(4c). These functional group interconversions allowed access to 
cinnamic acids and cinnanamide structures which are known to 
possess antimicrobial activity.15 
  The reaction conditions were now employed with analogous 
derivatives of the oxazolidinone heterocycle core to explore 
electronic effects on efficiency of catalysis (Scheme 9). The 
pyrrolidinone (6a), 2-thiazolidinone (6b) and 4-thiazolidinone 
(6c) structures gave modest-good yields in the C-H alkenylation 
reaction. These results manifest how subtle changes in hetero-
cycle electronics can affect C-H functionalisation efficiency un-
der the same reaction conditions.10a,16  
Mechanistic Studies 
  There have been multiple other examples of weak directing 
groups directing C-H alkenylation reactions such as carboxylic 
acids8c ketones8i, aldehydes8f and esters8h. As reported reaction 
conditions for these protocols are similar, it was of mechanistic 
interest to perform intermolecular competition experiments to 
create a reactivity order of directing groups. One equivalent of 
further weakly coordinating directing groups: ketone, acid, es-
ter and aldehyde (7a-d) were reacted under the optimized con-
ditions from this report with one equivalent of 3-phenyl-2-oxa-
zolidinone (1a) to compete with one equivalent of methyl acry-
late (2b) (Scheme 10). 
Scheme 8: Further Derivation of Alkenylated 3-Phenyloxa-
zolidinone 3b 
 
Scheme 9: Ruthenium Catalyzed Alkenylation of 5-Mem-
bered Heterocycles 
   
  These experimental insights show that the ketone directing 
group (7a) competes preferentially over the oxazolidinone 
whereas acids, aldehydes and esters give rise to a larger major-
ity of alkenylated aryloxazolidinone. This also allows under-
standing into potential functional group tolerance of this meth-
odology, where aromatic acyl derivatives of the aryloxazoli-
dinone would give rise to a large mixture of products which was 
observed experimentally when para-acetyl-N-aryloxazoli-
dinone was submitted to the reaction conditions. 
  Silver hexafluoroantimonate (AgSbF6) is a ubiquitous cata-
lytic partner to ruthenium para-cymene dimer.8c,8f It was of in-
terest to investigate whether it only acts as a catalyst activator 
or plays a further part in the reaction. Due to this, a proposed 
catalytically active monomeric species [Ru(p-cymene)(OAc)2] 
was subjected to the reaction conditions with and without the 
co-catalyst (Scheme 11). Interestingly no conversion to product 
was observed without the additive, highlighting its further im-
portance as a source of SbF6
 anion in the reaction. 
 
 
 
 Scheme 10: Intermolecular Competition Experiments with 
Weakly Coordinating Directing Groups 7a-d 
 
Scheme 11: Ru(II) Catalyzed C-H Alkenylation using a De-
fined Ruthenium Catalyst Monomer 
 
  Replacement of the aromatic C-H bonds with deuterium atoms 
gave the isotopically labelled structure [D]5-1a. This was sub-
mitted to the reaction conditions in order to investigate the po-
tential hydrogen incorporation into the final product. This 
would be indicative of a reversible cyclometalation. The result-
ing reaction gave rise to an 8% hydrogen incorporation into the 
ortho-C-D bond (Scheme 12), also affording the isotopically la-
belled product in a reduced but still good yield of 69%. 
Scheme 12: Ru(II)-Catalyzed Alkenylation of Isotopically 
Labelled Substrate 
 
  The kinetic isotope effect (KIE) of a substrate can give great 
insight into mechanism and give information about the rate lim-
iting sections of the catalytic cycle. This allows greater in-depth 
understanding of reaction tuning and optimization.17 Kinetic 
isotope analysis was carried out experimentally using two meth-
ods: initial rates by parallel reactions (Scheme 13a) and through 
intermolecular competition between 1a and [D]5-1a (Scheme 
13b). Both methods showed that the reaction had a kinetically 
relevant isotope effect, signifying that C-H cleavage is in or 
near the rate limiting step.  
Scheme 13: Experimental Investigation of Kinetic Isotope 
Effect 
 
Computational Mechanistic Studies 
  Density functional theory (DFT) calculations were undertaken 
to establish the mechanism and energetics of the reaction for 3-
phenyl-2-oxazolidinone 1a and methyl acrylate 2b.18 Previous 
studies have shown the importance of using corrections for dis-
persion, solvation and extended basis sets when treating large 
organometallic reaction systems that involve charged species. 
A similar approach was adopted in this work, with geometries 
initially optimized in the gas phase with the BP86 functional 
and a medium sized basis set (SDD for Ru and 6-31G** on all 
other atoms). The resultant free energies were then corrected for 
solvation (2-Me-THF), dispersion (Grimme’s D3-BJ parameter 
set) and an extended basis-set (cc-pVTZ for Ru and 6-
311++G** for all other atoms) giving rise to composite free en-
ergy differences ΔGMeTHF (1 atm, 25 °C) relative to complex A 
and separate species 1a and 2b.  
  Under the catalytic conditions, acetate from the copper com-
plex (Cu(OAc)2·H2O) breaks up the dimer [RuCl2(p-cymene)]2 
to form the in situ catalytically active intermediate A, [Ru(p-
cymene)(OAc)(1a)]+, with the silver compound (AgSbF6) re-
moving chloride anions from the solution. The cationic com-
plex A has the oxazolidinone coordinated through the carbonyl 
oxygen, one κ2-acetate and an η6 para-cymene ligand around 
the ruthenium center. Concerted metalation-deprotonation 
(CMD), also known as ambiphilic metal-ligand activation 
 (AMLA), occurs as a two-step reversible process (see Figure 2). 
The first step, via TS(A-B)1, involves κ2- κ1 displacement of 
acetate, by the approaching ortho C-H bond of 1a, to form an 
agostic intermediate INT(A-B), where the pendant oxygen of 
the acetate is directed towards the ortho H (O···H = 1.686 Å), 
thereby elongating the C-H bond from 1.091 Å to 1.148 Å. The 
second step, via TS(A-B)2, involves endergonic C-H bond 
cleavage to form a six-membered cyclometalate B (+4.0 kcal 
mol-1). Formation of the agostic intermediate, which involves 
breaking a strong Ru-O bond, determines the overall C-H acti-
vation barrier of 12.4 kcal mol-1. 
 
 
Figure 2: DFT calculated free energies (kcal mol-1) relative to A 
for the C-H activation of N-aryloxazolidinone 1a at [Ru(OAc)(p-
cymene)]+ in Me-THF.  
  Ligand substitution of acetic acid in B for methyl acrylate 2b 
forms four isomers of C, which differ with respect to the orien-
tation of the alkene at the ruthenium center. Despite the pre-1,2-
insertion intermediates C11,2 and C21,2 being more stable than 
the equivalent pre-2,1-insertion intermediates, the free energy 
barriers for 1,2-insertion (TS(C1-D1)1,2 and TS(C2-D2)1,2) are 
respectively 20.0 and 19.9 kcal mol-1, approximately 5 kcal mol-
1 higher than 2,1-insertion (see Figure 3 and Figure S1 in the 
supporting information). Therefore, 2,1-insertion of 2b into the 
Ru-C bond is regiosterically favored via TS(C1-D1)2,1 (13.8 
kcal mol-1) and TS(C2-D2)2,1 (14.9 kcal mol-1 ), placing the me-
thyl ester substituent next to the ruthenium in the exergonic 
eight-membered metallacycles either below (D12,1; -1.7 kcal 
mol-1) or above (D22,1; -1.3 kcal mol-1) the plane of the ruthena-
cycle (when looking at the complex from the position of the 
para-cymene ligand). 
 
Figure 3: DFT calculated free energies (kcal mol-1) relative to A 
and the free substrates, for the 2,1-insertion of methyl acrylate 2b 
into adduct C.  
  Unlike in previous functionalization studies with methyl acry-
late (by Davies and Macgregor19, who used 3-phenyl-pyrazole 
to form a seven-membered rhodacycle) for this 2,1-insertion no 
interaction is observed between Ru and the ester substituent in 
the eight-membered ruthenacycle. In fact, the increased size of 
the metallacycle restricts its ability to interconvert between con-
formers D12,1 and D22,1, as the preference for the boat-chair con-
formation reduces the flexibility of the metallacycle ring; this 
contrasts with the behavior that has been reported for similar, 
yet smaller, equivalent seven-membered intermediates.19 The 
stereochemistry of the 1,2-disubstituted alkene product 3b is 
determined exclusively by which β-hydrogen is transferred to 
the ruthenium center; from either above (Ha, Figure 4) or below 
(Hb) the plane of the ruthenacycle. 
 
Figure 4: Ruthenacycle D2,1 showing the position of Ha (above) 
and Hb (below) the plane of the metallacycle. D12,1 has the 
CO2Me substituent cis to Hb whilst D22,1 has the ester group cis 
to Ha 
  The β-hydrogen transfer process involves two steps: formation 
of an agostic intermediate followed by C-H cleavage, as the β-
H moves to the Ru center. Figure 5 shows the transfer of Ha, 
which lies above the plane of the ruthenacycle, for both D2,1 iso-
mers. In the case of D12,1, where the transferring hydrogen is 
trans to the ester group, formation of the agostic interaction be-
tween Ha and Ru proceeds via TS(D1-E1)1a (19.1 kcal mol
-1) 
to give intermediate INT(D1-E1)a (+13.1 kcal mol-1), and C-H 
cleavage occurs via TS(D1-E1)2a (13.9 kcal mol-1) to form the 
cis product E1cis (+10.4 kcal mol-1). For D22,1, with Ha cis to the 
ester group, formation of the agostic interaction proceeds via 
TS(D2-E2)1a (13.5 kcal mol-1), decreasing the Ru···Ha distance 
from 3.701 to 2.716 Å in INT(D2-E2)a (+5.8 kcal mol-1) before 
C-H cleavage via TS(D2-E2)2a (7.8 kcal mol-1) and formation 
of the experimentally observed trans 3b product [Ru(p-cy-
mene)(3b)(H)]+ (E2trans; +4.9 kcalmol-1). 
 
Figure 5: DFT calculated free energies (kcal mol-1) relative to A 
and the free substrates, for the β-Ha transfer from 2,1-insertion 
ruthenacycles (D2,1) in Me-THF.  
  The process of β-H transfer is more complicated for the “bot-
tom” hydrogen, Hb shown in Figure 6, as the formation of the 
agostic interaction between Hb and Ru (Ru···Hb decreasing to 
 2.4 Å) forces dissociation of the oxazolidinone group at the ru-
thenium center (Ru···O increasing to 3.4 Å). This raises the bar-
riers for the first step from D12,1 via TS(D1-E1)1b (17.5 kcal 
mol-1) and from D22,1  via TS(D2-E2)1b (31.9 kcal mol-1). The 
C-Hb bond is elongating by ~ 0.03 Å as the Ru-Hb distance de-
creases; this is a greater distortion than C-Ha (~ 0.01 Å) when 
the agostic intermediate is formed for the top β-H transfer. C-
Hb cleavage occurs via TS(D1-E1)2b (13.6 kcal mol
-1) and 
TS(D2-E2)2b (20.4 kcal mol-1) for D1 and D2 respectively to 
give intermediates E1ʹtrans (+9.7 kcal mol-1) and E2ʹcis (+14.1 
kcal mol-1). Reassociation of the oxazolidinone oxygen occurs 
via TS(E1ʹ-E1)trans (12.8 kcal mol-1) and TS(E2ʹ-E2)cis (16.8 
kcal mol-1) to form the equivalent E1trans (+11.3 kcal mol-1) and 
E2cis (+14.3 kcal mol-1) complexes, which are less stable than 
the preceding Eʹ complexes. 
 
Figure 6: DFT calculated free energies (kcal mol-1) relative to A 
and the free substrates, for the β-Hb transfer from 2,1-insertion 
ruthenacycles (D2,1) in Me-THF.  
  Based on the assumption that the energy difference of 0.4 kcal 
mol-1 between the two 2,1-insertion ruthenacycle complexes 
(D12,1 and D22,1) is small enough that both species are populated 
during the catalytic cycle, it is comforting to note that both 
ruthenacycle isomers preferentially form the trans 1,2-disubsti-
tuted alkene product over the cis stereoisomer. This agrees with 
experiment that only trans 3b is observed, and is due to H trans-
fer of different β-hydrogens (Ha or Hb). The free-energy differ-
ence between TS(D1-E1)1a and TS(D2-E2)1a suggests a pref-
erence of about 104 for formation of the trans product over the 
cis isomer. 
  The absence of a di-alkenylated product (3bdi) formed during 
the reaction was investigated, with the subsequent C-H activa-
tion of 3b at the remaining ortho C-H position modelled. The 
barrier for this activation was 15.4 kcal mol-1 (see Supporting 
Information, Table S2), 3 kcal mol-1 higher than activation of 
the initial C-H site in substrate 1b (TS(A-B)1 = +12.4 kcal mol-
1), hence 3b does not undergo a second C-H activation. The un-
usual isomeric preference 1ar / 1aq substrates were likewise 
studied. Here, the major and minor C-H activation pathways 
were modelled for 1ar (see Supporting Information, Table S3) 
and unsurprisingly the barrier for the major isomer pathway was 
lower in free energy, by 0.9 kcal mol-1. This small difference, 
and similar energies for 1arA and 1arAʹ, the major and minor iso-
mers of [Ru(p-cymene)(OAc)(1ar)]+ respectively, (ΔG = 0.4 
kcal mol-1) agree with the experimental observation of both iso-
mers, showing a slight energetic preference for the formation of 
the major isomer. 
  In order to estimate the Gibbs energy change for the uncata-
lyzed coupling of 1a to 2b to give 3b, the oxidation process also 
needs to be included (equation 1). The overall reaction may be 
considered as: 
1a  +  2b  +  ½O2    3b  +  H2O (1) 
for which the exergonic Gibbs energy change (at 25 °C) is -49 
kcal mol-1. This is the amount by which all the Gibbs energies 
relative to A must be reduced between one turnover of the cat-
alytic cycle and the next. (Note that the reaction path for the 
conversion from E2trans to A in the next cycle has not been in-
vestigated computationally.) The significance of this consider-
ation is that it allows the turnover-dependent intermediate and 
the turnover-dependent transition state to be identified as D22,1 
and TS(D2-E2)1a, respectively, which occur sequentially 
within the same turnover cycle (Figure 7); the possibility of the 
turnover-dependent transition state occurring in the subsequent 
cycle can be discounted in this case.20 Thus the computational 
modelling predicts the rate-determining step (as commonly un-
derstood) to be formation of the agostic intermediate immedi-
ately prior to β-hydride transfer. Under the experimental condi-
tions the oxidation step is undoubtedly mediated by Cu(OAc)2, 
although the detailed mechanism is unknown.21 However, for 
the present purpose it is necessary only to consider overall stoi-
chiometry and thermochemistry, not kinetics and mechanism 
for this stage of the turnover cycle. The calculated free energy 
changes ΔGMeTHF reported above (Figures 2 – 6) refer to a stand-
ard state of 1 atm for all species, but detailed considerations of 
the rate-determining step (or, in general, of the turnover-de-
pendent intermediate and transition state within a steady-state 
catalytic cycle)20 depend upon actual concentrations under ex-
perimental conditions. The relative Gibbs energies shown in 
Figure 7 are corrected for the change from 1 atm (concentration 
c1) to the standard reaction conditions (Table 1; concentration 
c2) by the term RTln(c1/c2) at temperature T = 120 °C. The lig-
and exchange step B  C (for which a transition structure has 
not been determined) becomes exergonic due to the larger rela-
tive concentration of alkene 2b, with the consequence that the 
free energies of the transition structures for the alkene insertion 
and -hydride transfer sections of the cycle are lowered with 
respect to those in the C-H activation section. The resulting pro-
file (Figure 7) shows four transition structures (TS(A-B)1, 
TS(A-B)2, TS(C2-D2)2,1 and TS(D2-E2)1a) all with quite sim-
ilar free energies. 
 
Kinetic Isotope Effects 
  Relative to A, the computational modelling predicts an intrin-
sic KIE kH5/kD5 = 2.2 for the C-H activation step. Since the pre-
ceding transition structure TS(A-B)1 for formation of the agos-
tic intermediate is calculated to be slightly higher in energy, the 
intrinsic KIE would be partially masked, leading to a reduced 
value for the observed isotope effect. The experimental KIE by 
direct comparison of initial reaction rates for 1a and [D]5-1a has 
a value of about 2, which seems to suggest that most of the in-
trinsic KIE is being expressed. The KIEs calculated for the in-
dividual agostic formation, migratory insertion, and β-hydride 
elimination steps are all essentially unity as expected (Scheme 
14). 
 Figure 7: DFT calculated free energies (kcal mol-1 relative to A) for the coupling of 1a and 2b to form 3b using a ruthenium catalyst at 120 
°C in Me-THF and at concentrations corresponding to the standard experimental conditions (Table 1).  
Scheme 14: Full Mechanism of Ruthenium-Catalyzed C-H Alkenylation including Kinetic and Energetic (kcal mol-1) DFT 
Contributions 
   The KIE determined by the method of intermolecular compe-
tition expresses the isotopic discrimination up to the first irre-
versible step of the cycle, relative to free starting material. It is 
known that cyclometallation is reversible (Scheme 12), leading 
to loss of deuterium from the ortho position of 1a. The product 
ratio determined in the competition experiment therefore re-
flects the isotope effect on cyclometallation. However, the in-
terpretation of the experimental isotope effect is complicated by 
at least two factors. First, the isotopic product ratio observed 
depends upon the degree of conversion, since starting from a 
1:1 mixture of isotopologues, a product ratio of 1:1 must be ob-
tained for 100% conversion: the observed isotope effect should 
be corrected for the fractional degree of conversion, which leads 
to a greater value for the KIE.22 Second, the fact that isotopic 
exchange at the ortho position is seen to take place during cy-
clometallation means that the proportion of deuterated 1a in the 
reaction mixture is reduced, leading to an increase in the appar-
ent value of the KIE. Numerical simulation shows that only a 
small percentage of isotopic exchange due to B  A reversibil-
ity is required to account for an apparent KIE of about 2.6 as 
observed for the intermolecular competition experiment. 
  We have reported the first use of the oxazolidinone directing 
group in ruthenium catalyzed C-H functionalization. This proof 
of concept of cyclometalation and subsequent functionalization 
was modeled on an alkenylation reaction. This led to the syn-
thesis of over 25 novel substituted N-aryloxazolidinone motifs 
with up to 94% yields with absolute mono-selectivity. This 
methodology granted access to biologically relevant derivatives 
of oxazolidinone pharmaceuticals and could be applied to late 
stage drug modification.  
  DFT calculations for most sections of the catalytic cycle sug-
gest why trans-3b is the only product isomer obtained, but yield 
very similar free energies for the transition states of several 
steps in the proposed mechanism using relative concentrations 
corresponding to the experimental conditions. The C-H activa-
tion step involves a KIE of kH/kD5  2 in apparent agreement 
with the observed value, but several reasons are noted why a 
direct comparison between calculation and experiment may not 
be warranted.  
Supporting Information. Full characterization, NMR spectra, 
computational data and crystallographic information is attached. 
This material is available free of charge via the Internet at 
http://pubs.acs.org.  
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